Danijela Lj Stojković

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Candida Albicans

Top Venues

Dalton transactions (Cambridge, England : 2003)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Kemal Ćorović, Danijela Lj Stojković, Đorđe S Petrović, Sandra S Jovičić Milić, Maja B Đukić, Ivana D Radojević, Ivana Raković, Milena Jurišević, Nevena Gajović, Marina Jovanović, Jovana Marinković, Ivan P Jovanovic, Bojan Stojanović
Newly synthesized palladium(II) complexes with dialkyl esters of ( S , S )-propylenediamine- N , N '-di-(2,2'-di-(4-hydroxy-benzil))acetic acid: in vitro investigation of biological activities and HSA/DNA binding. Dalton transactions (Cambridge, England : 2003) 53 (18) (2024)
Kemal Ćorović, Danijela Lj Stojković, Đorđe S Petrović, Sandra S Jovičić Milić, Maja B Đukić, Ivana D Radojević, Ivana Raković, Milena Jurišević, Nevena Gajović, Marina Jovanović, Jovana Marinković, Ivan P Jovanovic, Bojan Stojanović
Newly synthesized palladium(II) complexes with dialkyl esters of ( S , S )-propylenediamine- N , N '-di-(2,2'-di-(4-hydroxy-benzil))acetic acid: in vitro investigation of biological activities and HSA/DNA binding. Dalton transactions (Cambridge, England : 2003) (2024)
Kemal Ćorović, Danijela Lj Stojković, Đorđe S Petrović, Sandra S Jovičić Milić, Maja B Đukić, Ivana D Radojević, Ivana Raković, Milena Jurišević, Nevena Gajović, Marina Jovanović, Jovana Marinković, Ivan P Jovanovic, Bojan Stojanović
Newly synthesized palladium(II) complexes with dialkyl esters of ( S , S )-propylenediamine- N , N '-di-(2,2'-di-(4-hydroxy-benzil))acetic acid: in vitro investigation of biological activities and HSA/DNA binding. Dalton transactions (Cambridge, England : 2003) 53 (18) (2024)
Milica G Paunović, Miloš M Matić, Ana D Obradović, Verica V Jevtić, Danijela Lj Stojković, Branka I Ognjanović
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines. Drug development research (2021)